These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8171736)

  • 1. Carboplatin and oral etoposide in the treatment of patients with advanced breast cancer refractory to anthracyclines.
    Fountzilas G; Skarlos D; Theoharis D; Giannakakis T; Stathopoulos G
    Tumori; 1993 Dec; 79(6):389-92. PubMed ID: 8171736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
    Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
    Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
    Fountzilas G; Dimopoulos AM; Papadimitriou C; Kalogera-Fountzila A; Aravantinos G; Bafaloukos D; Athanassiades A; Nicolaides C; Keramopoulos A; Pavlidis N; Kosmidis P; Skarlos D
    Ann Oncol; 1998 Sep; 9(9):1031-4. PubMed ID: 9818080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
    Fields KK; Elfenbein GJ; Perkins JB; Hiemenz JW; Janssen WE; Zorsky PE; Ballester OF; Kronish LE; Foody MC
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):59-66. PubMed ID: 8211217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
    deMagalhaes-Silverman M; Rybka WB; Lembersky B; Bloom EJ; Lister J; Pincus SM; Voloshin M; Wilson J; Ball ED
    Am J Clin Oncol; 1996 Apr; 19(2):169-73. PubMed ID: 8610643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: a phase II study.
    Fried G; Stein ME; Haim N
    Med Pediatr Oncol; 2000 Jan; 34(1):10-3. PubMed ID: 10611578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of standard-dose carboplatin, cyclophosphamide, and etoposide in patients with metastatic breast cancer with previous exposure to anthracyclines.
    Recchia F; Nuzzo A; Lalli A; De Filippis S; Torchio P
    Am J Clin Oncol; 1997 Apr; 20(2):166-8. PubMed ID: 9124193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of carboplatin and etoposide activity in pretreated breast cancer patients.
    Viñolas N; Daniels M; Estapé J; Grau JJ; Palombo H; Solá C
    Am J Clin Oncol; 1992 Apr; 15(2):160-2. PubMed ID: 1553906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
    J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.
    Deltetto F; Durando A; Camanni M; Pesola D; Sberveglieri M; Arese P; Massobrio M
    Eur J Gynaecol Oncol; 1997; 18(3):185-7. PubMed ID: 9174832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines.
    Vassilomanolakis M; Koumakis G; Barbounis V; Demiri M; Pateras H; Efremidis AP
    Ann Oncol; 2000 Sep; 11(9):1155-60. PubMed ID: 11061611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial.
    Johnson DH; DeVore R; Greco FA; Walls J; Thomas M; Hande KR; Hainsworth JD
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):50-6. PubMed ID: 1329223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.
    Icli F; Akbulut H; Uner A; Yalcin B; Baltali E; Altinbas M; Coşkun S; Komurcu S; Erkisi M; Demirkazik A; Senler FC; Sencan O; Büyükcelik A; Boruban C; Onur H; Zengin N; Sak SD
    Br J Cancer; 2005 Feb; 92(4):639-44. PubMed ID: 15726120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study.
    Eiermann W; Achterrath W; Lenaz L; Hepp H
    Cancer Chemother Pharmacol; 1991; 27(5):389-93. PubMed ID: 1998999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P; Sørensen P; Rose C
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
    van der Gaast A; Bontenbal M; Planting AS; Kok TC; Splinter TA
    Ann Oncol; 1994 Nov; 5(9):858-60. PubMed ID: 7661927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
    Smith DC; Chay CH; Dunn RL; Fardig J; Esper P; Olson K; Pienta KJ
    Cancer; 2003 Jul; 98(2):269-76. PubMed ID: 12872344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of carboplatin and etoposide in metastatic breast cancer.
    Crown J; Hakes T; Reichman B; Lebwohl D; Gilewski T; Surbone A; Currie V; Yao TJ; Hudis C; Seidman A
    Cancer; 1993 Feb; 71(4):1254-7. PubMed ID: 8435802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.